New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
March 21, 2014
11:30 EDTMOH, WLP, CI, ESRX, CNCAnalyst sees Express Scripts benefiting from WellPoint member growth
After health insurer WellPoint (WLP) estimated that the number of people using its health insurance would rise by 1M-1.3M this year, Citigroup expects Express scripts to benefit from the increase. WHAT'S NEW: WellPoint announced that it expects its medical member base to rise by 1M-1.3M in 2014. The company also increased its 2014 earnings per share guidance to at least $8.20 per share, up from $8. In a note to investors earlier today, Citigroup analyst Garen Sarafian wrote that WellPoint had increased the outlook for its medical membership base from previous levels and that the insurer now predicts that the number of its medical members will rise by 3%-4% in 2014. Express Scripts, which provides pharmacy benefit management services for WellPoint, obtained over 12% of its 2013 revenue from WellPoint, the analyst stated. WellPoint's stronger than expected growth could lift Express Script's 2014 earnings per share by up to 7c, wrote Sarafian. He kept a $92 price target and Buy rating on Express Script. PRICE ACTION: In late morning trading, Express Scripts lost 0,4% to $77.65 and WellPoint added 0.7% to $100.45. WHAT'S NOTABLE: Other health insurers are rising in the wake of WellPoint's announcement, with Centene (CNC), Cigna (CI), and Molina (MOH) all higher by about 1%.
News For ESRX;WLP;CNC;CI;MOH From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
November 21, 2014
08:01 EDTCNCCentene jv selected to provide correctional healthcare In Vermont
Subscribe for More Information
November 19, 2014
10:21 EDTCNCHigh option volume stocks
Subscribe for More Information
November 14, 2014
16:52 EDTCIGreenlight Capital gives quarterly update on stakes
Subscribe for More Information
16:39 EDTESRXBerkshire Hathaway gives quarterly update on stakes
Subscribe for More Information
14:53 EDTESRXCVS Express Scripts implementing drug price controls, says Cleveland Research
Cleveland Research believes that CVS (CVS) and Express scripts are implementing rebates and price controls on drug. The firm expects the companies to increase their focus on controlling durg prices next year, and adds that they have already itnroduced prior authorization criteria for hepatitis drug. Publicly traded drug companies include AstraZeneca (AZN), Bristol-Myers (BMY), Eli Lilly (LLY), GlaxoSmithKline (GSK), Johnson & Johnson (JNJ), Merck (MRK), Novartis (NVS), Pfizer (PFE), Roche (RHHBY) and Sanofi (SNY). Makers of hepatits c drugs include AbbVie (ABBV) and Gilead (GILD),
08:04 EDTWLPWellPoint, Boehringer Ingelheim announce first project under collaboration
Boehringer Ingelheim Pharmaceuticals, WellPoint and HealthCore, announced that the companies are commencing a research project to identify and address unmet medical needs across populations of mutual interest. The first stage of the project will focus on non-valvular atrial fibrillation and will examine disease prevalence, treatment complications, such as hospital readmissions, and the use of evidence-based guidelines. This project is the first under the parties’ five-year research collaboration agreement, signed earlier this year. Information gathered through the NVAF project is intended to provide the basis for the collaborative development of healthcare interventions, which can be evaluated within WellPoint’s affiliated health plans and provider networks.
November 13, 2014
10:01 EDTCNCOn The Fly: Analyst Downgrade Summary
Today's noteworthy downgrades include: ATK (ATK) downgraded to Hold from Buy at Argus... Adeptus Health (ADPT) downgraded to Hold from Buy at Deutsche Bank... American Woodmark (AMWD) downgraded to Neutral from Buy at Longbow... Avnet (AVT) downgraded to Sell from Neutral at Goldman... Baxano Surgical (BAXS) downgraded to Sell from Buy at Summer Street... Beazer Homes (BZH) downgraded to Neutral from Overweight at JPMorgan... Bristol-Myers (BMY) downgraded to Equal Weight from Overweight at Morgan Stanley... Centene (CNC) downgraded to Market Perform from Outperform at FBR Capital... Cherry Hill Mortgage (CHMI) downgraded to Equal Weight from Overweight at Barclays... Discover (DFS) downgraded to Hold from Buy at Deutsche Bank... Fleetmatics (FLTX) downgraded to Neutral from Buy at BofA/Merrill... Gazprom (OGZPY) downgraded to Neutral from Overweight at JPMorgan... Jabil Circuit (JBL) downgraded to Neutral from Buy at Goldman... LabCorp (LH) downgraded to Hold from Buy at Deutsche Bank... Laredo Petroleum (LPI) downgraded at BMO Capital... Macy's (M) downgraded to Market Perform from Outperform at Wells Fargo... Madison Square Garden (MSG) downgraded to Equal Weight from Overweight at Morgan Stanley... Marvell (MRVL) downgraded to Sell from Neutral at Goldman... Meritor (MTOR) downgraded to Neutral from Overweight at Piper Jaffray... Swedbank (SWDBY) downgraded to Underperform from Sector Perform at RBC Capital... TransGlobe (TGA) downgraded to Sector Perform from Outperform at Scotia Capital... UIL Holdings (UIL) downgraded to Hold from Buy at Argus... Verint Systems (VRNT) downgraded to Fair Value from Buy at CRT Capital... ZAIS Financial (ZFC) downgraded to Equal Weight from Overweight at Barclays.
06:29 EDTCNCCentene downgraded to Market Perform from Outperform at FBR Capital
FBR Capital downgraded Centene to Market Perform citing valuation following the recent rally in shares.
November 12, 2014
08:58 EDTCNC, WLP, CI, MOHManaged Care earnings risk low from King vs. Burwell, says Leerink
Leerink believes the Supreme Court decision to the King vs. Burwell case carries low earnings risk for Managed Care companies. The case to determine the legality of Exchange subsidies administered by the Federal Government carries less than 2% and 3% of earnings risk for 2014 and 2015 estimates, respectively, Leerink believes. The firm says Humana (HUM) and Cigna (CI) are currently losing money on Exchanges, and thus could benefit from any Federal Exchange membership loss. Leerink lists Aetna (AET), Centene (CNC), WellPoint (WLP) and Molina Healthcare (MOH) as being most impacted.
08:02 EDTCNCCredit Suisse to hold a conference
Subscribe for More Information
November 11, 2014
12:55 EDTWLP, MOH, CI, CNCWorkarounds to likely protect insurers from Supreme Court decision, says Wedbush
Subscribe for More Information
November 10, 2014
15:53 EDTWLPCredit Suisse to hold a conference
Healthcare Conference is being held in Scottsdale, Arizona on November 10-13 with webcasted company presentations to begin on November 11 at 10:30 am; not all company presentations may be webcasted. Webcast Link
07:34 EDTWLPWellPoint has strong momentum heading into 2015, says UBS
UBS said WellPoint has strong momentum across all business segments heading into 2015. The firm expects the company's national account business to grow and sees the company having earnings power from the public exchanges, Medicare, and Medicaid. UBS reiterates its Buy rating on WellPoint and raised its price target to $150 from $144.
06:29 EDTCICigna to restructure HIV prescription drug benefits, WSJ reports
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use